Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
Authors:
- Vanessa D. JonssonVJVanessa D. Jonsson
- Collin M. BlakelyCBCollin M. Blakely
- Luping LinLLLuping Lin
- Saurabh AsthanaSASaurabh Asthana
- Victor OlivasVOVictor Olivas
- Matthew A. GubensMGMatthew A. Gubens
- Nikolai MatniNMNikolai Matni
- Boris C. BastianBBBoris C. Bastian
- Barry S. TaylorBTBarry S. Taylor
- John C. DoyleJDJohn C. Doyle
- Trever G. BivonaTBTrever G. Bivona
Preprint
Abstract
1 The success of targeted cancer therapy is limited by drug resistance that can result from tumor genetic heterogeneity. The current approach to address resistance typically involves initiating a new treatment after clinical/radiographic disease progression, ultimately resulting in futility in most patients. Towards a potential alternative solution, we developed a novel computational framework that uses human cancer profiling data to systematically identify dynamic, pre-emptive, and sometimes non-intuitive treatment strategies that can better control tumors in real-time. By studying lung adenocarcinoma clinical specimens and preclinical models, our computational analyses revealed that the best anti-cancer strategies addressed existing resistant subpopulations as they emerged dynamically during treatment. In some cases, the best computed treatment strategy used unconventional therapy switching while the bulk tumor was responding, a prediction we confirmed in vitro. The new framework presented here could guide the principled implementation of dynamic molecular monitoring and treatment strategies to improve cancer control.Keywords
All Related Versions
- Published version: Scientific Reports, 7 (1), srep44206.
This publication has 44 references indexed in Scilit:
- Clinical Implications of Genomic Discoveries in Lung CancerNew England Journal of Medicine, 2016
- A framework for understanding and targeting residual disease in oncogene-driven solid cancersNature Medicine, 2016
- Exploiting Temporal Collateral Sensitivity in Tumor Clonal EvolutionCell, 2016
- Toward understanding and exploiting tumor heterogeneityNature Medicine, 2015
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencingScience, 2014
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionScience, 2014
- Evolutionary dynamics of cancer in response to targeted combination therapyeLife, 2013
- Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer ModelingScience Translational Medicine, 2011
- Adaptive TherapyCancer Research, 2009
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretationsJournal of Theoretical Biology, 2006